期刊文献+

KDR、MC2R和PCNA在产醛固酮腺瘤与肾上腺皮质增生病变中的表达和意义

The expressions and significance of kinase domain receptor,melanocortin-2 receptor and proliferating cell nuclear antigen in aldosterone-producing adenoma and adrenal cortical hyperplasia
下载PDF
导出
摘要 目的:探讨激酶插入区受体(KDR)、促肾上腺皮质激素受体2(MC2R)和增殖细胞核抗原(PCNA)在产醛固酮腺瘤(APA)与肾上腺皮质增生(IHA)中的表达和意义。方法:应用免疫组织化学技术检测KDR、MC2R和PCNA在APA和IHA病变组织中(各40例)的表达情况。结果:APA组织中KDR、MC2R和PCNA的阳性表达率分别为40.0%、32.5%和85.0%;IHA组织中KDR、MC2R和PCNA的阳性表达率分别为65.0%、62.5%和77.5%;2种病变组织中,KDR、MC2R和PCNA的表达强度差异均有统计学意义(P〈0.05-P〈0.01)。结论:KDR、MC2R和PCNA在IHA病变的发生、发展中起重要作用,对于鉴别APA和IHA病变具有重要的参考意义。 Objective: To explore the expressions and significance of kinase domain receptor( KDR),melanocortin-2 receptor( MC2R)and proliferating cell nuclear antigen( PCNA) in aldosterone-producing adenoma( APA) and adrenal cortical hyperplasia( IHA).Methods: The expressions of KDR,MC2 R and PCNA in 40 cases APA and 40 cases IHA lesions were detected by immunohistochemistry. Results: The positive expression rates of KDR,MC2 R and PCNA in APA lesions were 40. 0%,32. 5% and85. 0%,respectively. The expression rates of KDR,MC2 R and PCNA in IHA lesions were 65. 0%,62. 5% and 77. 5%,respectively.The differences of KDR,MC2 R and PCNA expressions between APA and IHA were statistically significant( P〈0. 05 to P〈0. 01).Conclusions: The KDR,MC2 R and PCNA play an important role in the occurrence and development of IHA,which have important reference meaning in the differentiation of APA and IHA lesions.
出处 《蚌埠医学院学报》 CAS 2016年第1期41-43,共3页 Journal of Bengbu Medical College
基金 上海市卢湾区卫生局科研课题项目(卢卫科1010)
关键词 产醛固酮腺瘤 肾上腺皮质增生 激酶插入区受体 促肾上腺皮质激素受体2 增殖细胞核抗原 aldosterone-producing adenoma adrenal cortical hyperplasia kinase domain receptor melanocortin-2 receptor proliferating cell nuclear antigen
  • 相关文献

参考文献8

  • 1LOH KC, KOAY ES, KHAW MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore[J]. J Clin Endocrinol Metab,2000,85(8):2854.
  • 2MULATERO P,DLUHY RG,GIACCHETTI G,et al. Diagnosis of primary aldosteronism:from screening to subtype differentiation[J]. Trends Endocrinol Metab,2005,16(3):114.
  • 3SAHAR DE,YANG GP,LONGAKER MT,et al. Surgical applicationof cDNA microarray technique[J]. Surgery,2005,138(3):399.
  • 4MILAN A,PUGLISI E,MAGNINO D,et al. Left atrial enlargement in essential hypertension:role in the assessment of subclinical hypertension heart disease[J]. Blood Press,2012,21(2):88.
  • 5BIECHE I, VACHER S, VALLERAND D, et al. Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays:evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings[J]. BMC Cancer,2014,14(1):173.
  • 6TAKEKOSHI K, ISOBE K, YASHIRO T. et al. Expression of vascular endothelial growth factor(VEGF) and its cognate receptors in human pheochromocytomas[J]. Life Sci,2004,74(7):863.
  • 7GORRIGAN RJ,GUASTI L,KING P,et al. Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland[J]. Mol Endocrinol,2011,46(3):227.
  • 8STRZALKA W. ZIEMIENOWICZ A. Proliferating cell nuclear antigen(PCNA):a key factor in DNA replication and cell cycle regulation[J]. Ann Bot,107(7):1127.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部